Abstract
We compared the activity of norfloxacin (MK-0366), a new orally absorbable derivative of naladixic acid, with those of other antipseudomonal agents against Pseudomonas aeruginosa. Norfloxacin was the most active against both gentamicin-susceptible and gentamicin-resistant strains, having 90% minimal inhibitory concentrations of 2 and 8 micrograms/ml, respectively. This excellent in vitro activity may make norfloxacin effective for oral therapy of P. aeruginosa urinary tract infections.
MeSH Terms
Anti-Bacterial Agents/pharmacology
Drug Resistance, Microbial
Gentamicins/pharmacology
Microbial Sensitivity Tests
Nalidixic Acid/analogs & derivatives,pharmacology
Norfloxacin
Pseudomonas aeruginosa/drug effects
Chemicals
Anti-Bacterial Agents
Gentamicins
Nalidixic Acid
Norfloxacin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Forward K R
Harding G K
Gray G J
Urias B A
Ronald A R
References (6)
6 references, click to expand
-
Carbenicillin resistance in Pseudomonas aeruginosa from clinical material.
Br Med J. 1969 Jul 19;3(5663):141-3
PMID: 4978352
-
In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1982 Apr;21(4):670-2
PMID: 6211142
-
Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography.
Antimicrob Agents Chemother. 1982 May;21(5):808-10
PMID: 6213199
-
Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.
Antimicrob Agents Chemother. 1982 May;21(5):848-51
PMID: 6213200
-
Norfloxacin and the antibacterial gamma pyridone beta carboxylic acids.
J Antimicrob Chemother. 1982 Jul;10(1):25-30
PMID: 6213593
-
Antibacterial activity of norfloxacin.
Antimicrob Agents Chemother. 1983 Jan;23(1):15-8
PMID: 6219617